Chimaphilin inhibits proliferation and induces apoptosis in multidrug resistant osteosarcoma cell lines through insulin-like growth factor-I receptor (IGF-IR) signaling.

作者: Wan Daqian , Wang Chuandong , Qu Xinhua , Ai Songtao , Dai Kerong

DOI: 10.1016/J.CBI.2015.05.008

关键词:

摘要: Chimaphilin, an active compound separated from pyrola, possesses the highly efficient antitumor activities. Insulin-like growth factor-I receptor (IGF-IR) plays important role in tumor cell survival. To look for effective strategies interrupting IGF-IR signaling pathway, we found that chimaphilin can inhibit tyrosine kinase activity of IGF-IR. Chimaphilin inhibited both drug-sensitive and drug-resistant osteosarcoma lines a time dose-dependent manner; however, it showed relatively little toxicity normal osteoblast lines. increase sensitivity doxorubicin doxorubicin-resistant Additionally, small interfering RNA downregulation expression also caused resensitization to doxorubicin. Above all, conclude represents valuable natural source may potentially be applicable reversing phenotype therapy.

参考文章(21)
ROBERT J. MCKENNA, CHARLES P. SCHWINN, K. Y. SOONG, NORMAN L. HIGINBOTHAM, SARCOMATA OF THE OSTEOGENIC SERIES (OSTEOSARCOMA, FIBROSARCOMA, CHONDROSARCOMA, PAROSTEAL OSTEOGENIC SARCOMA, AND SARCOMATA ARISING IN ABNORMAL BONE). AN ANALYSIS OF 552 CASES. Journal of Bone and Joint Surgery, American Volume. ,vol. 48, pp. 1- 26 ,(1966) , 10.2106/00004623-196648010-00001
Maria C. Velez-Yanguas, Steven Hirschfeld, Cynthia Chavez Kappel, Lee J. Helman, Human Osteosarcoma Cell Lines Are Dependent on Insulin-like Growth Factor I for in Vitro Growth Cancer Research. ,vol. 54, pp. 2803- 2807 ,(1994)
Andrew A Butler, Vicky A Blakesley, Maria Tsokos, Vasiliki Pouliki, Teresa L Wood, Derek LeRoith, None, Stimulation of Tumor Growth by Recombinant Human Insulin-like Growth Factor-I (IGF-I) Is Dependent on the Dose and the Level of IGF-I Receptor Expression Cancer Research. ,vol. 58, pp. 3021- 3027 ,(1998)
Michele Rubini, Atsushi Hongo, Consuelo D'Ambrosio, Renato Baserga, The IGF-I receptor in mitogenesis and transformation of mouse embryo cells: role of receptor number. Experimental Cell Research. ,vol. 230, pp. 284- 292 ,(1997) , 10.1006/EXCR.1996.3430
N. Chalhoub, G. Zhu, X. Zhu, S. J. Baker, Cell type specificity of PI3K signaling in Pdk1- and Pten-deficient brains Genes & Development. ,vol. 23, pp. 1619- 1624 ,(2009) , 10.1101/GAD.1799609
Lisa Mirabello, Rebecca J. Troisi, Sharon A. Savage, Osteosarcoma incidence and survival rates from 1973 to 2004: Data from the Surveillance, Epidemiology, and End Results Program Cancer. ,vol. 115, pp. 1531- 1543 ,(2009) , 10.1002/CNCR.24121
Krzysztof Reiss, Barbara Valentinis, Xiao Tu, Shi-Qiong Xu, Renato Baserga, Molecular markers of IGF-I-mediated mitogenesis. Experimental Cell Research. ,vol. 242, pp. 361- 372 ,(1998) , 10.1006/EXCR.1998.4113
Carlos Garcı́a-Echeverrı́a, Mark A Pearson, Andreas Marti, Thomas Meyer, Juergen Mestan, Johann Zimmermann, Jiaping Gao, Josef Brueggen, Hans-Georg Capraro, Robert Cozens, Dean B Evans, Doriano Fabbro, Pascal Furet, Diana Graus Porta, Janis Liebetanz, Georg Martiny-Baron, Stephan Ruetz, Francesco Hofmann, In vivo antitumor activity of NVP-AEW541—A novel, potent, and selective inhibitor of the IGF-IR kinase Cancer Cell. ,vol. 5, pp. 231- 239 ,(2004) , 10.1016/S1535-6108(04)00051-0
E. Kramárová, C.A. Stiller, The international classification of childhood cancer. International Journal of Cancer. ,vol. 68, pp. 759- 765 ,(1996) , 10.1002/(SICI)1097-0215(19961211)68:6<759::AID-IJC12>3.0.CO;2-W
Meenali M. Chitnis, John S.P. Yuen, Andrew S. Protheroe, Michael Pollak, Valentine M. Macaulay, The type 1 insulin-like growth factor receptor pathway. Clinical Cancer Research. ,vol. 14, pp. 6364- 6370 ,(2008) , 10.1158/1078-0432.CCR-07-4879